The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3

By Ma Q.   Dudas B.   Hejna M.   Cornelli U.   Lee J.M.   Lorens S.   Mervis R.   Hanin I.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 5, 2002-03 ,pp. : 447-453

Elsevier

Access to resources Recommend Favorite

BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE

By Walenga J.M.   Jeske W.P.   Bara L.   Samama M.M.   Fareed J.  

Thrombosis Research, Vol. 86, Iss. 1, 1997-04 ,pp. : 1-36

Elsevier

Access to resources Recommend Favorite

Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production

By Hogasen A.K.M.   Abrahamsen T.G.  

Thrombosis Research, Vol. 80, Iss. 2, 1995-10 ,pp. : 179-184

Elsevier

Access to resources Recommend Favorite

Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study

By Kurokawa Y.   Matoba R.   Takemasa I.   Nakamori S.   Tsujie M.   Nagano H.   Dono K.   Umeshita K.   Sakon M.   Ueno N.   Kita H.   Oba S.   Ishii S.   Kato K.   Monden M.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1004-1012

Elsevier

Access to resources Recommend Favorite

Molecular Profiling and Research of Therapeutic Targets

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 586-589

Karger

Access to resources Recommend Favorite